Vasant Narasimhan, vent de renouveau chez Novartis | Les Echos
Vas Narasimhan | «Debemos reinventar la medicina y hacer que los fármacos innovadores lleguen a todos» - XL Semanal
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis CEO sees 'better place' with Covid by year-end | Mint
Quand Novartis séduit plus que Roche - Le Temps
Novartis CEO on how yoga & lessons from his grandparents help him take big professional decisions
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis CEO says preparedness for a new pandemic has not improved
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis on LinkedIn: Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global… | 281 comments
Vas Narasimhan - Novartis | LinkedIn
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis CEO on Acquisitions, AI, Weight-Loss Drugs - YouTube
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis CEO Narasimhan aims to surmount $9B patent cliff with 20 blockbuster launches | Fierce Pharma
Biotech can become a powerhouse in India': Novartis' Narasimhan | Mint
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis CEO explains how AI will impact drug development
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
Performance slump takes toll on Novartis' CEO's 2022 payout
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Novartis names Indian-origin Vasant Narasimhan as new CEO | Mint
